IMMUNITYBIO, INC. Debt Securities, Held-to-maturity, Current
IMMUNITYBIO, INC. (IBRX) had Debt Securities, Held-to-maturity, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:HeldToMaturitySecuritiesCurrent · last filed 2020-03-25
- 2019-12-31: Debt Securities, Held-to-maturity, Current $0.00.
- 2019-09-30: Debt Securities, Held-to-maturity, Current $0.00.
- 2019-06-30: Debt Securities, Held-to-maturity, Current $0.00.
- 2019-03-31: Debt Securities, Held-to-maturity, Current $0.00.
| Period end | Debt Securities, Held-to-maturity, Current |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-25 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $723.00K 10-K · filed 2020-03-25 |
| 2018-09-30 | $723.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $361.00K 10-Q · filed 2018-08-06 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |